| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −23.7× | −1.7× | |
| Price / Book | 12.6× | 2.0× | |
| Price / Sales | — | 4.0× | — |
| Price / Free cash flow | −55.0× | −1.5× | |
| EV / EBITDA | −22.3× | −1.2× | |
| Earnings yield | −4.2% | −14.4% | |
| Free cash flow yield | −1.8% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,296.03 | +4.49% | $1.22T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.69 | +2.32% | $625.83B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $288.28 | +1.98% | $509.42B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $418.59 | +2.88% | $375.72B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $147.83 | +2.92% | $364.72B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $152.83 | +1.75% | $281.73B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.60 | +2.84% | $261.48B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $684.17 | +0.71% | $252.97B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $435.27 | +2.43% | $235.32B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.78 | +1.77% | $193.16B | 22.3× | 37.5% | +29.9% |
